ID   KLF8_HUMAN              Reviewed;         359 AA.
AC   O95600; B4DJN3; E7EQQ8; L0R3U8; L0R4U2; Q2M246; Q59GV5; Q5HYQ5; Q5JXP7;
AC   Q6MZJ7; Q9UGC4;
DT   02-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2001, sequence version 2.
DT   28-JUN-2023, entry version 187.
DE   RecName: Full=Krueppel-like factor 8;
DE   AltName: Full=Basic krueppel-like factor 3;
DE   AltName: Full=Zinc finger protein 741;
GN   Name=KLF8; Synonyms=BKLF3, ZNF741;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Gorski J.L., MacDonald M., Vananthwerp M., Burright E.N., Bialecki M.;
RL   Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4), AND ALTERNATIVE SPLICING.
RX   PubMed=23134681; DOI=10.1096/fj.12-220319;
RA   Camacho-Vanegas O., Till J., Miranda-Lorenzo I., Ozturk B., Camacho S.C.,
RA   Martignetti J.A.;
RT   "Shaking the family tree: Identification of novel and biologically active
RT   alternatively spliced isoforms across the KLF family of transcription
RT   factors.";
RL   FASEB J. 27:432-436(2013).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, SUBUNIT, AND TISSUE SPECIFICITY.
RX   PubMed=10756197; DOI=10.1093/nar/28.9.1955;
RA   van Vliet J., Turner J., Crossley M.;
RT   "Human Kruppel-like factor 8: a CACCC-box binding protein that associates
RT   with CtBP and represses transcription.";
RL   Nucleic Acids Res. 28:1955-1962(2000).
RN   [9]
RP   FUNCTION.
RX   PubMed=12820964; DOI=10.1016/s1097-2765(03)00179-5;
RA   Zhao J., Bian Z.C., Yee K., Chen B.P., Chien S., Guan J.L.;
RT   "Identification of transcription factor KLF8 as a downstream target of
RT   focal adhesion kinase in its regulation of cyclin D1 and cell cycle
RT   progression.";
RL   Mol. Cell 11:1503-1515(2003).
RN   [10]
RP   SUMOYLATION AT LYS-67, INTERACTION WITH PIAS1; PIAS2 AND PIAS4, FUNCTION,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-67 AND LYS-217.
RX   PubMed=16617055; DOI=10.1074/jbc.m513135200;
RA   Wei H., Wang X., Gan B., Urvalek A.M., Melkoumian Z.K., Guan J.-L.,
RA   Zhao J.;
RT   "Sumoylation delimits KLF8 transcriptional activity associated with the
RT   cell cycle regulation.";
RL   J. Biol. Chem. 281:16664-16671(2006).
RN   [11]
RP   INACTIVATION OF 9AATAD MOTIF.
RX   PubMed=31375868; DOI=10.1007/s00018-019-03251-w;
RA   Piskacek M., Havelka M., Jendruchova K., Knight A., Keegan L.P.;
RT   "The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with
RT   valines and intron reservoirs.";
RL   Cell. Mol. Life Sci. 77:1793-1810(2020).
CC   -!- FUNCTION: Transcriptional repressor and activator. Binds to CACCC-boxes
CC       promoter elements. Also binds the GT-box of cyclin D1 promoter and
CC       mediates cell cycle progression at G(1) phase as a downstream target of
CC       focal adhesion kinase (FAK). {ECO:0000269|PubMed:10756197,
CC       ECO:0000269|PubMed:12820964, ECO:0000269|PubMed:16617055}.
CC   -!- SUBUNIT: Interacts with corepressor CtBP2. Interacts with PIAS1, PIAS2,
CC       and PIAS4; the interaction with each ligase sumoylates KLF8.
CC       {ECO:0000269|PubMed:10756197, ECO:0000269|PubMed:16617055}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16617055}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=O95600-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95600-3; Sequence=VSP_045460;
CC       Name=3;
CC         IsoId=O95600-4; Sequence=VSP_047480, VSP_045460;
CC       Name=4;
CC         IsoId=O95600-5; Sequence=VSP_047481;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10756197}.
CC   -!- DOMAIN: The 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors. In KLF8, the motif is
CC       inactive. {ECO:0000269|PubMed:31375868}.
CC   -!- PTM: Sumoylation at Lys-67 represses transcriptional activity and
CC       reduces cell cycle progression into the G(1) phase. Has no effect on
CC       subcellular location. {ECO:0000269|PubMed:16617055}.
CC   -!- SIMILARITY: Belongs to the Sp1 C2H2-type zinc-finger protein family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U28282; AAC99849.1; -; mRNA.
DR   EMBL; HF546207; CCO02793.1; -; mRNA.
DR   EMBL; HF546208; CCO02794.1; -; mRNA.
DR   EMBL; HF546209; CCO02795.1; -; mRNA.
DR   EMBL; AK296156; BAG58895.1; -; mRNA.
DR   EMBL; AB209004; BAD92241.1; ALT_SEQ; mRNA.
DR   EMBL; BX641066; CAE46033.1; ALT_SEQ; mRNA.
DR   EMBL; AL050309; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BX322609; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC105130; AAI05131.1; -; mRNA.
DR   EMBL; BC112109; AAI12110.1; -; mRNA.
DR   CCDS; CCDS14373.1; -. [O95600-1]
DR   CCDS; CCDS55428.1; -. [O95600-3]
DR   CCDS; CCDS87749.1; -. [O95600-4]
DR   RefSeq; NP_001152768.1; NM_001159296.2. [O95600-3]
DR   RefSeq; NP_001311028.1; NM_001324099.1. [O95600-4]
DR   RefSeq; NP_001311029.1; NM_001324100.1. [O95600-5]
DR   RefSeq; NP_001311031.1; NM_001324102.1. [O95600-1]
DR   RefSeq; NP_009181.2; NM_007250.5. [O95600-1]
DR   RefSeq; XP_005262034.1; XM_005261977.2.
DR   RefSeq; XP_005262036.1; XM_005261979.3.
DR   RefSeq; XP_006724638.1; XM_006724575.2. [O95600-3]
DR   AlphaFoldDB; O95600; -.
DR   SMR; O95600; -.
DR   BioGRID; 116435; 326.
DR   ELM; O95600; -.
DR   IntAct; O95600; 317.
DR   MINT; O95600; -.
DR   STRING; 9606.ENSP00000417303; -.
DR   GlyGen; O95600; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O95600; -.
DR   PhosphoSitePlus; O95600; -.
DR   BioMuta; KLF8; -.
DR   jPOST; O95600; -.
DR   MassIVE; O95600; -.
DR   PaxDb; O95600; -.
DR   PeptideAtlas; O95600; -.
DR   ProteomicsDB; 17622; -.
DR   ProteomicsDB; 50947; -. [O95600-1]
DR   Antibodypedia; 13002; 249 antibodies from 32 providers.
DR   DNASU; 11279; -.
DR   Ensembl; ENST00000374928.7; ENSP00000364063.3; ENSG00000102349.18. [O95600-3]
DR   Ensembl; ENST00000468660.6; ENSP00000417303.1; ENSG00000102349.18. [O95600-1]
DR   Ensembl; ENST00000640927.1; ENSP00000492126.1; ENSG00000102349.18. [O95600-4]
DR   GeneID; 11279; -.
DR   KEGG; hsa:11279; -.
DR   MANE-Select; ENST00000468660.6; ENSP00000417303.1; NM_007250.5; NP_009181.2.
DR   UCSC; uc004dur.4; human. [O95600-1]
DR   AGR; HGNC:6351; -.
DR   CTD; 11279; -.
DR   DisGeNET; 11279; -.
DR   GeneCards; KLF8; -.
DR   HGNC; HGNC:6351; KLF8.
DR   HPA; ENSG00000102349; Tissue enhanced (skin).
DR   MIM; 300286; gene.
DR   neXtProt; NX_O95600; -.
DR   OpenTargets; ENSG00000102349; -.
DR   PharmGKB; PA30141; -.
DR   VEuPathDB; HostDB:ENSG00000102349; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000161062; -.
DR   HOGENOM; CLU_002678_33_0_1; -.
DR   InParanoid; O95600; -.
DR   OMA; KMTSPPF; -.
DR   OrthoDB; 3168417at2759; -.
DR   PhylomeDB; O95600; -.
DR   TreeFam; TF350556; -.
DR   PathwayCommons; O95600; -.
DR   SignaLink; O95600; -.
DR   SIGNOR; O95600; -.
DR   BioGRID-ORCS; 11279; 7 hits in 793 CRISPR screens.
DR   ChiTaRS; KLF8; human.
DR   GeneWiki; KLF8; -.
DR   GenomeRNAi; 11279; -.
DR   Pharos; O95600; Tbio.
DR   PRO; PR:O95600; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; O95600; protein.
DR   Bgee; ENSG00000102349; Expressed in esophagus squamous epithelium and 161 other tissues.
DR   ExpressionAtlas; O95600; baseline and differential.
DR   Genevisible; O95600; HS.
DR   GO; GO:0016235; C:aggresome; IDA:HPA.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:NTNU_SB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd21440; KLF8_N; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 3.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR23235:SF46; KRUEPPEL-LIKE FACTOR 8; 1.
DR   PANTHER; PTHR23235; KRUEPPEL-LIKE TRANSCRIPTION FACTOR; 1.
DR   Pfam; PF00096; zf-C2H2; 3.
DR   SMART; SM00355; ZnF_C2H2; 3.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 2.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 3.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; DNA-binding; Isopeptide bond; Metal-binding; Nucleus;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..359
FT                   /note="Krueppel-like factor 8"
FT                   /id="PRO_0000047176"
FT   ZN_FING         274..298
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         304..328
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         334..356
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          216..235
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           85..93
FT                   /note="9aaTAD; inactive"
FT                   /evidence="ECO:0000269|PubMed:31375868"
FT   CROSSLNK        67
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT   VAR_SEQ         1..27
FT                   /note="MVDMDKLINNLEVQLNSEGGSMQVFKQ -> MSLPEDGMSSGHFRSPQLVTW
FT                   S (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:23134681"
FT                   /id="VSP_047480"
FT   VAR_SEQ         216..299
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:23134681"
FT                   /id="VSP_047481"
FT   VAR_SEQ         254..359
FT                   /note="PAAMAQMQGEESLDLKRRRIHQCDFAGCSKVYTKSSHLKAHRRIHTGEKPYK
FT                   CTWDGCSWKFARSDELTRHFRKHTGIKPFRCTDCNRSFSRSDHLSLHRRRHDTM -> R
FT                   EAL (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:23134681"
FT                   /id="VSP_045460"
FT   MUTAGEN         67
FT                   /note="K->R: Abolishes sumoylation. No change in nuclear
FT                   location. Increases transcriptional activity and cell cycle
FT                   progression. Abolishes sumoylation; when associated with
FT                   R-217."
FT                   /evidence="ECO:0000269|PubMed:16617055"
FT   MUTAGEN         217
FT                   /note="K->R: No change in sumoylation. Abolishes
FT                   sumoylation; when associated with R-67."
FT                   /evidence="ECO:0000269|PubMed:16617055"
FT   CONFLICT        167
FT                   /note="S -> I (in Ref. 3; BAG58895)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        263
FT                   /note="E -> G (in Ref. 1; AAC99849)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   359 AA;  39314 MW;  F8FDCC1FD477C04F CRC64;
     MVDMDKLINN LEVQLNSEGG SMQVFKQVTA SVRNRDPPEI EYRSNMTSPT LLDANPMENP
     ALFNDIKIEP PEELLASDFS LPQVEPVDLS FHKPKAPLQP ASMLQAPIRP PKPQSSPQTL
     VVSTSTSDMS TSANIPTVLT PGSVLTSSQS TGSQQILHVI HTIPSVSLPN KMGGLKTIPV
     VVQSLPMVYT TLPADGGPAA ITVPLIGGDG KNAGSVKVDP TSMSPLEIPS DSEESTIESG
     SSALQSLQGL QQEPAAMAQM QGEESLDLKR RRIHQCDFAG CSKVYTKSSH LKAHRRIHTG
     EKPYKCTWDG CSWKFARSDE LTRHFRKHTG IKPFRCTDCN RSFSRSDHLS LHRRRHDTM
//
